Current filters:


Popular Filters

1001 to 1025 of 1223 results

US House Bill will establish inspection parity, improve US drug supply


Ranking US Congress Member Henry Waxman, Health Subcommittee Ranking Member Frank Pallone, Representative…

GenericsLegalNorth AmericaPharmaceuticalPoliticsRegulation

New US GAO report highlights critical role of generics in containing health spending


Prescription drug spending in the USA reached $307 billion in 2010 - an increase of $135 billion since…

GenericsHealthcareNorth AmericaPricing

Prospects for global generic drugs market viewed by F&S


While the global generic pharmaceuticals market is expected to peak in 2012 as a result of the patent…

GenericsGlobalMarkets & Marketing

EU Commission proposes faster access to medicines for patients


With the intention of getting new medicines to the market faster, the European Commission yesterday proposed…

EuropeGenericsMarkets & MarketingPharmaceuticalPricingRegulation

Hi-Tech and Mylan update on generics


US generic drugmaker Hi-Tech Pharmacal (Nasdaq: HITK) says that the US Food and Drug Administration has…

GenericsMarkets & MarketingNeurologicalNorth AmericaRegulation

Frontage and Fanghui Pharma launch $10 million collaboration


Emerging Chinese pharmaceutical company Luohe Fanghui Pharmaceutical has launched a new globalization…

Asia-PacificFanghui PharmaceuticalsFinancialFrontage LaboratoriesGenericsNorth AmericaRegulation

Future for biosimilars hugely promising, Momenta CEO tells GPhA meeting


Craig Wheeler, chief executive of Momenta Pharmaceuticals (Nasdaq: MNTA) discussed the promise and prospects…

BiotechnologyGenericsMarkets & MarketingMomenta PharmaceuticalsResearch

Medicines are good value for money in UK, says DoH report


A UK Department of Health released yesterday endorses the current voluntary agreement between the DoH…


Australia’s GMiA advises pharmacists on maximizing profitability in 2012


Pharmacists in Australia need to act now to try to increase their dispensaries' profitability in 2012,…

Asia-PacificGenericsMarkets & MarketingPricing

Sanofi considers expanding in Ukraine pharma market


French drug major Sanofi (Euronext: SAN) is considering a massive expansion into the Ukrainian pharmaceutical…

EuropeGenericsMarkets & MarketingPharmaceuticalSanofi

Ranbaxy posts $586 million loss due to charges


India’s largest drugmaker Ranbaxy Laboratories (RAB: BO), which is 64% owned by Japan’s Daiichi…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

Mylan gets tentative FDA approval for generic Epzicom


US generics major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Laboratories has received tentative…

Anti-viralsEpzicomGenericsGlaxoSmithKlineMylan LaboratoriesNorth AmericaPfizerRegulationViiV Healthcare

Mylan 4th-qtr profits beat expectations, but not sales


US generic drugs major Mylan (Nasdaq: MYL) yesterday posted financial results for the three months and…

FinancialGenericsMylan Laboratories

Generic drugs key to unlocking savings for Australian economy, says MJA


A report in the latest issue of the Medical Journal of Australia (MJA), has backed the case for the government…


Opportunities for Pharma in narcolepsy


The narcolepsy therapeutics developmental pipeline is weak, with only six molecules in development, providing…

BioprojectCephalonGenericsMarkets & MarketingNeurologicalNuvigilPharmaceuticalProvigilResearchTeva Pharmaceutical IndustriesUCBXyrem

Pfizer and Hisun flesh-out plans for generics JV in China


Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceutical (SSE Code: 600267), a leading…

Asia-PacificGenericsMergers & AcquisitionsPfizerZhejiang Hisun Pharma

Actavis to debut generic Aricept in EU markets as patents expire


Icelandic generics firm Actavis yesterday announced the launch of donepezil, a generic copy of Eisai…

ActavisAriceptdonepezilEisaiEuropeGenericsMarkets & MarketingNeurologicalPfizer

Merck & Co sets up marketing JV in Brazil


Merck & Co (NYSE: MRK) says it has formed a new joint venture with Supera Farma Laboratorios, a Brazilian…

CristaliaEurofarmaGenericsMarkets & MarketingMerck & CoMergers & AcquisitionsPharmaceuticalSouth AmericaSupera Farma

Teva Pharma strong sales growth helped by acquisitions


Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) reported fourth-quarter 2011 results…

CephalonFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Impending biologics patent expiries creates huge opportunity for European biosimilars makers


The biosimilars manufacturing industry is at a nascent stage. However, the impending patent expiries…

BiotechnologyEuropeGenericsMarkets & MarketingPatents

1001 to 1025 of 1223 results

Company Spotlight



Back to top